• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基孔肯雅病毒感染人类患者在极早期急性期引发的细胞因子和趋化因子。

Cytokines and chemokines triggered by Chikungunya virus infection in human patients during the very early acute phase.

作者信息

Tanabe Ithallo S B, Santos Elane C, Tanabe Eloiza L L, Souza Stephannie J M, Santos Fabio E F, Taniele-Silva Jamile, Ferro Jean F G, Lima Magliones C, Moura Adriana A, Anderson Leticia, Bassi Ênio J

机构信息

IMUNOREG-Grupo de Pesquisa em Regulação da Resposta Imune, Laboratório de Pesquisas em Virologia e Imunologia, Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Alagoas, Maceió, Alagoas, Brazil.

Laboratório Central de Saúde Pública de Alagoas, Maceió, Alagoas, Brazil.

出版信息

Trans R Soc Trop Med Hyg. 2019 Nov 1;113(11):730-733. doi: 10.1093/trstmh/trz065.

DOI:10.1093/trstmh/trz065
PMID:31365117
Abstract

BACKGROUND

The immune response against the Chikungunya virus (CHIKV) during the very early acute phase is not fully elucidated. Therefore we explored the cytokine and chemokine profile triggered by CHIKV in infected patients.

METHODS

Cytokines, chemokines and C5a anaphylatoxin were analysed in serum from CHIKV-infected patients during the viraemic phase (mean 2.97±1.27 d after illness onset) compared with a healthy group.

RESULTS

CHIKV-infected patients had a significant increase of interferon-α (IFN-α), interleukin-6 (IL-6), interleukin-8 (CXCL8/IL-8), interleukin-10 (IL-10), interferon-γ (IFN-γ), monokine induced by interferon-γ (CXCL9/MIG), monocyte chemoattractant protein-1 (CCL2/MCP-1), interferon-γ-induced protein-10 (CXCL10/IP-10) and complement C5a anaphylatoxin.

CONCLUSIONS

The very early acute immune response triggered against CHIKV leads to an increase in pro-inflammatory immune mediators such as IFN-γ and its induced chemokines, and a high level of C5a anaphylatoxin as a result of complement activation.

摘要

背景

基孔肯雅病毒(CHIKV)在极早期急性期的免疫反应尚未完全阐明。因此,我们探究了CHIKV在感染患者中引发的细胞因子和趋化因子谱。

方法

将CHIKV感染患者病毒血症期(发病后平均2.97±1.27天)血清中的细胞因子、趋化因子和C5a过敏毒素与健康组进行分析比较。

结果

CHIKV感染患者的α干扰素(IFN-α)、白细胞介素-6(IL-6)、白细胞介素-8(CXCL8/IL-8)、白细胞介素-10(IL-10)、γ干扰素(IFN-γ)、γ干扰素诱导的单核因子(CXCL9/MIG)、单核细胞趋化蛋白-1(CCL2/MCP-1)、γ干扰素诱导蛋白-10(CXCL10/IP-10)和补体C5a过敏毒素显著增加。

结论

针对CHIKV触发的极早期急性免疫反应导致促炎免疫介质如IFN-γ及其诱导的趋化因子增加,以及补体激活产生的高水平C5a过敏毒素。

相似文献

1
Cytokines and chemokines triggered by Chikungunya virus infection in human patients during the very early acute phase.基孔肯雅病毒感染人类患者在极早期急性期引发的细胞因子和趋化因子。
Trans R Soc Trop Med Hyg. 2019 Nov 1;113(11):730-733. doi: 10.1093/trstmh/trz065.
2
Clinical, Virological, and Immunological Profiles of DENV, ZIKV, and/or CHIKV-Infected Brazilian Patients.巴西登革热病毒、寨卡病毒和/或基孔肯雅热病毒感染患者的临床、病毒学和免疫学特征。
Intervirology. 2020;63(1-6):33-45. doi: 10.1159/000510223. Epub 2020 Sep 23.
3
Cytokines in acute chikungunya.急性基孔肯雅热中的细胞因子
PLoS One. 2014 Oct 24;9(10):e111305. doi: 10.1371/journal.pone.0111305. eCollection 2014.
4
Proinflammatory Cytokines and Chemokines as Biomarkers of Persistent Arthralgia and Severe Disease After Chikungunya Virus Infection: A 5-Year Follow-Up Study in Southern Thailand.促炎细胞因子和趋化因子作为基孔肯雅病毒感染后持续性关节痛和严重疾病的生物标志物:泰国南部的一项 5 年随访研究。
Viral Immunol. 2019 Dec;32(10):442-452. doi: 10.1089/vim.2019.0064. Epub 2019 Nov 12.
5
Determination of Toll-like receptor-induced cytokine profiles in the blood and cerebrospinal fluid of Chikungunya patients.基孔肯雅热患者血液和脑脊液中Toll样受体诱导的细胞因子谱的测定。
Neuroimmunomodulation. 2014;21(6):338-46. doi: 10.1159/000358240. Epub 2014 Apr 23.
6
Acute-Phase Levels of CXCL8 as Risk Factor for Chronic Arthralgia Following Chikungunya Virus Infection.血清 CXCL8 水平与基孔肯雅热病毒感染后慢性关节痛的相关性研究
Front Immunol. 2021 Oct 1;12:744183. doi: 10.3389/fimmu.2021.744183. eCollection 2021.
7
Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection.在急性基孔肯雅病毒感染期间,血浆病毒载量和基孔肯雅 IgM 抗体的存在与细胞因子/趋化因子水平的相关性。
J Med Virol. 2014 Aug;86(8):1393-401. doi: 10.1002/jmv.23875. Epub 2014 Feb 13.
8
A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection.急性基孔肯雅病毒感染患者免疫特征的系统荟萃分析
J Infect Dis. 2015 Jun 15;211(12):1925-35. doi: 10.1093/infdis/jiv049. Epub 2015 Jan 29.
9
Acute Zika Virus Infection in an Endemic Area Shows Modest Proinflammatory Systemic Immunoactivation and Cytokine-Symptom Associations.急性寨卡病毒感染在流行地区表现为适度的促炎全身性免疫激活和细胞因子症状关联。
Front Immunol. 2018 May 3;9:821. doi: 10.3389/fimmu.2018.00821. eCollection 2018.
10
Elevated Complement Activation Fragments and C1q-Binding Circulating Immune Complexes in Varied Phases of Chikungunya Virus Infection.在基孔肯雅病毒感染的不同阶段,补体激活片段和 C1q 结合的循环免疫复合物升高。
Curr Microbiol. 2024 Jun 24;81(8):242. doi: 10.1007/s00284-024-03732-7.

引用本文的文献

1
Pathogenesis and clinical management of arboviral diseases.虫媒病毒病的发病机制与临床管理
World J Virol. 2025 Mar 25;14(1):100489. doi: 10.5501/wjv.v14.i1.100489.
2
Acute Immunological Profile and Prognostic Biomarkers of Persistent Joint Pain in Chikungunya Fever: A Systematic Review.基孔肯雅热持续性关节疼痛的急性免疫学特征及预后生物标志物:一项系统评价
Yale J Biol Med. 2024 Dec 19;97(4):473-489. doi: 10.59249/RQYJ3197. eCollection 2024 Dec.
3
Comparison of Chikungunya Virus-Induced Disease Progression and Pathogenesis in Type-I Interferon Receptor-Deficient Mice (A129) and Two Wild-Type (129Sv/Ev and C57BL/6) Mouse Strains.
Ⅰ型干扰素受体缺陷型(A129)小鼠与两种野生型(129Sv/Ev 和 C57BL/6)小鼠中寨卡病毒诱导的疾病进展和发病机制的比较。
Viruses. 2024 Sep 27;16(10):1534. doi: 10.3390/v16101534.
4
Chronic Rheumatologic Disease in Chikungunya Virus Fever: Results from a Cohort Study Conducted in Piedecuesta, Colombia.基孔肯雅病毒热中的慢性风湿性疾病:在哥伦比亚彼德库埃斯塔进行的一项队列研究结果
Trop Med Infect Dis. 2024 Oct 19;9(10):247. doi: 10.3390/tropicalmed9100247.
5
Pathogenicity and virulence of chikungunya virus.基孔肯雅病毒的致病性和毒力。
Virulence. 2024 Dec;15(1):2396484. doi: 10.1080/21505594.2024.2396484. Epub 2024 Sep 1.
6
Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions.基孔肯雅病毒疫苗:解决流行病学困境、新出现概念及免疫干预措施的十年进展
Front Microbiol. 2024 Jul 22;15:1413250. doi: 10.3389/fmicb.2024.1413250. eCollection 2024.
7
Innate immune response in patients with acute Chikungunya disease.急性基孔肯雅热患者的固有免疫应答。
Med Microbiol Immunol. 2023 Aug;212(4):279-290. doi: 10.1007/s00430-023-00771-y. Epub 2023 Jun 7.
8
Understanding the Biology and Immune Pathogenesis of Chikungunya Virus Infection for Diagnostic and Vaccine Development.了解基孔肯雅热病毒感染的生物学和免疫发病机制,用于诊断和疫苗开发。
Viruses. 2022 Dec 23;15(1):48. doi: 10.3390/v15010048.
9
Role of cytokines, chemokines, C3a, and mannose-binding lectin in the evolution of the chikungunya infection.细胞因子、趋化因子、C3a和甘露糖结合凝集素在基孔肯雅热感染演变中的作用。
Am J Clin Exp Immunol. 2022 Jun 15;11(3):51-63. eCollection 2022.
10
Acute-Phase Levels of CXCL8 as Risk Factor for Chronic Arthralgia Following Chikungunya Virus Infection.血清 CXCL8 水平与基孔肯雅热病毒感染后慢性关节痛的相关性研究
Front Immunol. 2021 Oct 1;12:744183. doi: 10.3389/fimmu.2021.744183. eCollection 2021.